[
  {
    "ts": "2026-01-21T12:11:01+00:00",
    "headline": "Amgen (AMGN) Expands Obesity Strategy With Ro Collaboration on GLP-1 Therapies",
    "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the best undervalued wide moat stocks. On January 13, 2026, an announcement came regarding the Ro and Amgen Inc. (NASDAQ:AMGN) collaboration. Ro, a U.S. telehealth firm, alongside Amgen, aims to investigate barriers patients face in accessing obesity treatments, including GLP-1 drugs such as Novo Nordisk’s Ozempic and Eli Lilly’s […]",
    "url": "https://finance.yahoo.com/news/amgen-amgn-expands-obesity-strategy-121101061.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "824c792e-c545-3d09-8882-66f25c349abb",
      "content": {
        "id": "824c792e-c545-3d09-8882-66f25c349abb",
        "contentType": "STORY",
        "title": "Amgen (AMGN) Expands Obesity Strategy With Ro Collaboration on GLP-1 Therapies",
        "description": "",
        "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the best undervalued wide moat stocks. On January 13, 2026, an announcement came regarding the Ro and Amgen Inc. (NASDAQ:AMGN) collaboration. Ro, a U.S. telehealth firm, alongside Amgen, aims to investigate barriers patients face in accessing obesity treatments, including GLP-1 drugs such as Novo Nordisk’s Ozempic and Eli Lilly’s […]",
        "pubDate": "2026-01-21T12:11:01Z",
        "displayTime": "2026-01-21T12:11:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/89c0b31c8a49a4b2c6733fddd0910df8",
          "originalWidth": 4069,
          "originalHeight": 2713,
          "caption": "Amgen (AMGN) Expands Obesity Strategy With Ro Collaboration on GLP-1 Therapies ",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sunxx6hqXfBWKrzfL3htQg--~B/aD0yNzEzO3c9NDA2OTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/89c0b31c8a49a4b2c6733fddd0910df8.cf.webp",
              "width": 4069,
              "height": 2713,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2LdiLb4t.zgVLda0bwZNgg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/89c0b31c8a49a4b2c6733fddd0910df8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-amgn-expands-obesity-strategy-121101061.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-amgn-expands-obesity-strategy-121101061.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-21T12:10:45+00:00",
    "headline": "AbbVie (ABBV) Looks to Deepen Its Push Into Rapidly Growing Obesity-Treatment Market",
    "summary": "AbbVie Inc. (NYSE:ABBV) is one of the 10 Goldman Sachs undervalued stocks to invest in. On January 14, 2026, Reuters reported that AbbVie Inc. (NYSE:ABBV) is looking to deepen its push into the rapidly growing obesity-treatment market, outlining its plans at the JPMorgan Healthcare Conference. The company’s plans center on GUBamy, an amylin-mimetic weight-loss drug […]",
    "url": "https://finance.yahoo.com/news/abbvie-abbv-looks-deepen-push-121045476.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "8d42e3f4-ae24-3a22-b2ad-17de10ae72cb",
      "content": {
        "id": "8d42e3f4-ae24-3a22-b2ad-17de10ae72cb",
        "contentType": "STORY",
        "title": "AbbVie (ABBV) Looks to Deepen Its Push Into Rapidly Growing Obesity-Treatment Market",
        "description": "",
        "summary": "AbbVie Inc. (NYSE:ABBV) is one of the 10 Goldman Sachs undervalued stocks to invest in. On January 14, 2026, Reuters reported that AbbVie Inc. (NYSE:ABBV) is looking to deepen its push into the rapidly growing obesity-treatment market, outlining its plans at the JPMorgan Healthcare Conference. The company’s plans center on GUBamy, an amylin-mimetic weight-loss drug […]",
        "pubDate": "2026-01-21T12:10:45Z",
        "displayTime": "2026-01-21T12:10:45Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/ae3aff8170c32ab72e21b7d307dd751f",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "AbbVie (ABBV) Looks to Deepen Its Push Into Rapidly Growing Obesity-Treatment Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QJoE63tFdMpnnrAbqprcaw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/ae3aff8170c32ab72e21b7d307dd751f.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Gi43WiQpLk0J.NMrpOdajw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/ae3aff8170c32ab72e21b7d307dd751f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-abbv-looks-deepen-push-121045476.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-abbv-looks-deepen-push-121045476.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "GUBRA.CO"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]